What are the guidelines for taking Slynd (drospirenone) as a contraceptive option?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Slynd (Drospirenone) Contraceptive Guidelines

Slynd is a progestin-only pill containing 4 mg drospirenone that can be started anytime if pregnancy is reasonably excluded, requires backup contraception for 7 days if started more than 1 day after menses begins, and offers more flexibility than traditional progestin-only pills with a 24-hour missed pill window. 1

Indications

Slynd (drospirenone 4 mg) is FDA-approved for:

  • Prevention of pregnancy in females of reproductive potential 2
  • Treatment of moderate acne vulgaris in women ≥14 years who desire oral contraception 2
  • Treatment of premenstrual dysphoric disorder (PMDD) symptoms in women choosing oral contraception (note: this indication applies to combination drospirenone/ethinyl estradiol formulations, not Slynd specifically) 2

How to Start Slynd

Timing of Initiation

  • Can be started anytime if the provider is reasonably certain the patient is not pregnant 1
  • No examination or testing required before initiation 1

Backup Contraception Requirements

  • If started ≤1 day after menses begins: No backup contraception needed 1
  • If started >1 day after menses begins: Use backup contraception (condoms) or abstain from intercourse for 7 days 1

This represents a key difference from traditional norethindrone/norgestrel progestin-only pills, which require only 2 days of backup contraception 1.

Dosing Instructions

Daily Administration

  • Take one tablet at the same time every day 2
  • Can be taken with or without food 2
  • Preferably after evening meal or at bedtime 2
  • Failure rate increases with missed or incorrectly taken pills 2

Pill Pack Structure

The specific formulation referenced in FDA labeling (drospirenone/ethinyl estradiol combination) contains:

  • 24 active hormone tablets (brown to reddish-brown) 2
  • 4 inactive tablets (white to off-white) on days 25-28 2

For Slynd specifically (drospirenone-only), the formulation differs but the same-time daily dosing principle applies 1.

Managing Missed Pills

Single Missed Pill

  • Take the missed pill as soon as remembered 2
  • Continue taking remaining pills at usual time (even if taking two pills same day) 2

Critical Timing Window

The drospirenone-only formulation requires 7 consecutive days of backup contraception if pills are missed beyond the first day after menses, which is longer than traditional progestin-only pills 1. This provides more flexibility than norethindrone/norgestrel POPs that have stricter timing requirements 3.

Switching from Other Methods

From Another Birth Control Pill

  • Start Slynd on the same day a new pack of the previous pill would have been started 2

From Patch or Vaginal Ring

  • Start when the next application would have been due 2

From Injection

  • Start when the next injection would have been due 2

From IUD or Implant

  • Start on the day of removal 2

Expected Bleeding Patterns

Withdrawal Bleeding

  • Usually occurs within 3 days following the last active tablet 2

Breakthrough Bleeding or Spotting

  • Continue taking pills as directed if spotting/breakthrough bleeding occurs 2
  • This bleeding is usually transient and without significance 2
  • If persistent or prolonged, consult healthcare provider 2

Missed Withdrawal Bleeding

  • If one period is missed and dosing schedule was not followed: Consider pregnancy 2
  • If two consecutive periods are missed even with adherence: Rule out pregnancy 2
  • Discontinue if pregnancy is confirmed 2

Unique Advantages of Drospirenone

Pharmacologic Properties

  • Drospirenone is a fourth-generation progestogen derived from spironolactone with antimineralocorticoid and antiandrogenic activity 4, 5
  • Resembles natural progesterone more closely than traditional synthetic progestogens 5
  • The 4 mg drospirenone-only formulation effectively inhibits ovulation without requiring an estrogen component 4

Clinical Benefits

  • More favorable bleeding profile compared to traditional progestin-only pills 3
  • Greater flexibility for delayed or missed pills while maintaining efficacy 3
  • May prevent sodium retention and associated weight gain seen with some contraceptives 5, 6

Important Precautions

Pre-Initiation Assessment

  • Blood pressure measurement required before starting combined hormonal contraceptives (though Slynd is progestin-only, this applies to combination drospirenone formulations) 7, 8
  • No routine examination required for progestin-only pills if medical history is negative 8

Drug Interactions

  • Certain anticonvulsants (phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine) may reduce effectiveness 1
  • Rifampin or rifabutin may reduce effectiveness 1
  • St. John's wort may reduce effectiveness 1
  • Broad-spectrum antibiotics, antifungals, and antiparasitics do not affect efficacy 1

Special Populations

  • HIV medications: Most antiretrovirals are compatible with progestin-only pills 1
  • Breastfeeding: Progestin-only pills can be started anytime postpartum, including immediately 1

Common Pitfalls to Avoid

  • Do not delay initiation waiting for next menstrual period—can start anytime if not pregnant 1
  • Do not confuse backup contraception requirements: Drospirenone POP requires 7 days (not 2 days like traditional POPs) if started >1 day after menses 1
  • Do not discontinue for breakthrough bleeding in first 3-6 months—this is expected and usually resolves 7
  • Do not assume pregnancy protection before 7 consecutive days of pills if not started within first day of menses 1, 2
  • Emphasize STI protection: All contraceptives require consistent condom use for STI prevention 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

New Contraception Update - Annovera, Phexxi, Slynd, and Twirla.

Current obstetrics and gynecology reports, 2022

Research

Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2000

Research

Drospirenone/ethinyl estradiol.

Drugs of today (Barcelona, Spain : 1998), 2008

Guideline

Management of Heavy Menstrual Bleeding in Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Contraception Guidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.